Cargando…

Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma

Tumor cells can vary epigenetically during ionizing irradiation (IR) treatment. These epigenetic variegations can influence IR response and shape tumor aggressiveness. However, epigenetic disturbance of histones after IR, implicating in IR responsiveness, has been elusive. Here, we investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Hak Jun, Hwang, Soon Young, Nguyen, Ngoc Hoan, Lee, Ik Jae, Lee, Eun Jeong, Seong, Jinsil, Lee, Jong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681868/ https://www.ncbi.nlm.nih.gov/pubmed/31362469 http://dx.doi.org/10.14348/molcells.2019.2280

Ejemplares similares

The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2012)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
por: Lee, Hsin-Lun, et al.
Publicado: (2023)

Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation
por: Hwang, Soon Young, et al.
Publicado: (2020)

Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments
por: Lee, Ik Jae, et al.
Publicado: (2016)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
por: Kim, Kyoung-Jin, et al.
Publicado: (2017)

Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021)

Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022)

Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma
por: Brandt, Elisa F., et al.
Publicado: (2022)

High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
por: Kim, Taehyung, et al.
Publicado: (2016)

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2022)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
por: Liu, Kwei-Yan, et al.
Publicado: (2018)

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
por: Lee, Byung Min, et al.
Publicado: (2021)

Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study
por: Lee, Ik Jae, et al.
Publicado: (2011)

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
por: Seong, Jinsil
Publicado: (2009)

Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
por: Cha, Hyejung, et al.
Publicado: (2017)

Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma
por: Lee, Byung min, et al.
Publicado: (2023)

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Yoon, Hong In, et al.
Publicado: (2016)

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
por: Park, Sehhoon, et al.
Publicado: (2022)

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study
por: Kim, Nalee, et al.
Publicado: (2022)

Identification of key genes and important histone modifications in hepatocellular carcinoma
por: Liu, Yu-Xian, et al.
Publicado: (2020)

Strategic application of radiotherapy for hepatocellular carcinoma
por: Choi, Seo Hee, et al.
Publicado: (2018)

Efficacy of Radiomics in Predicting Oncologic Outcome of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma
por: Park, Jong Won, et al.
Publicado: (2023)

The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
por: Choi, Sae Byeol, et al.
Publicado: (2009)

Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma
por: Park, Sangjoon, et al.
Publicado: (2018)

Re-Irradiation of Hepatocellular Carcinoma: Clinical Applicability of Deformable Image Registration
por: Lee, Dong Soo, et al.
Publicado: (2016)

Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12
por: Giordano, Frank A., et al.
Publicado: (2019)

CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
por: Mezzapelle, Rosanna, et al.
Publicado: (2022)

Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
por: Wu, Chia-Jen, et al.
Publicado: (2018)

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment
por: He, Ke, et al.
Publicado: (2020)

CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice
por: Koo, Hwa Seon, et al.
Publicado: (2021)

LPS-Induced Migration of Peritoneal B-1 Cells is Associated with Upregulation of CXCR4 and Increased Migratory Sensitivity to CXCL12
por: Moon, Hana, et al.
Publicado: (2012)

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines
por: Rim, Chai Hong, et al.
Publicado: (2016)

CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment
por: Giallongo, Cesarina, et al.
Publicado: (2022)

The role of histone modifications: from neurodevelopment to neurodiseases
por: Park, Jisu, et al.
Publicado: (2022)

Predictive Factors of Palliative Radiotherapy Response and Survival in Patients with Spinal Metastases from Hepatocellular Carcinoma
por: Choi, Chihwan, et al.
Publicado: (2015)

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2023)

Radiation-induced alterations in histone modification patterns and their potential impact on short-term radiation effects
por: Friedl, Anna A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jsk4il5q0api4f2jjt3vip7fso